Alentis Therapeutics AG
Developing Claudin-1 antibodies for cancer and fibrosis
Read moreThese trailblazers have scaled beyond expectations—becoming industry leaders, job creators, and global ambassadors of Swiss excellence. Their journeys reflect the power of vision, resilience, and innovation. Discover the startups that are transforming industries and inspiring the world shapers of tomorrow.
Developing Claudin-1 antibodies for cancer and fibrosis
Read morePromoting IMMUNE TOLERANCE, ameliorating disease
Read moreOnline tools to edit PDFs
Read moreInnovative solutions for sustainable agriculture
Read moreTumor analysis platform
Read morePlanted meats
Read moreSmart Data Capture
Read moreSimulators for medical training and education
Read more